Current Edition

10. Pyoderma Gangrenosum...
Regulatory

Patient Selection Bias in Oncology Clinical Trials

Randomised clinical trials are the gold standard for evaluating new treatments and moreover, they have become part of everyday practice. Many international guidelines recommend RCT …

Continue Reading →
clinical trial
Regulatory

Risk Assessment in Clinical Trials

Risks are an integral part of clinical trials. We routinely come across various risks while managing clinical trials, which are related to quality, safety, timeline, …

Continue Reading →